Dianthus Therapeutics to Participate in Two Investor Conferences
Dianthus Therapeutics, a clinical-stage biotech specializing in therapies for severe autoimmune diseases, announced participation in the Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June 2026 with executive-led fireside chats and investor meetings.